Approval · Notice of Compliance 26446 · 2021
LEVEMIR: Notice of Compliance 26446
Issued August 12, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26446
- Date
- August 12, 2021
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVEMIR | Not yet assigned | — |
Medicinal ingredients
- INSULIN DETEMIR 100 UNIT per 1ML